Investing in Radiology Clinician-Scientists
Supporting radiology clinician-scientists is essential for innovation — a strategic investment that can transform patient care and the future of academic medicine.
Read moreACR Data Science Institute’s AI Central had a busy month, adding a new product to the Transparent-AI program and 12 products to the directory.
A new product was added to our Transparent-AI program, which is designed to increase transparency in imaging AI and help end users have better informed discussions and selection criteria when making decisions about which algorithm might be most appropriate for their local target population.
Visage Imaging Inc. joined the Transparent-AI program with their product Visage Breast Density. Visage Breast Density is a software application that assesses breast density from a mammography study and provides a density category A, B, C, or D according to the ACR BI-RADS Atlas 5th Edition to aid radiologists in the assessment of breast tissue composition.
Transparent-AI consists of voluntarily provided data elements solicited from participating imaging AI manufacturers who currently have an FDA-cleared product in the U.S. market. Manufacturers who participate in this program will receive the Transparent-AI badge on their product listing.
Our AI Central directory has also been updated with 12 new products. This information is pulled directly from FDA 510K documents and updated by ACR staff. With this latest update, we see many newly cleared FDA products designed for chest x-rays.
New products include:
FEops HEARTguideTM, FEops HEARTguideTM ALPACA
TruPlan Computed Tomography (CT) Imaging Software
Viz HDS, Viz Volume Plus, Viz ICH+
Investing in Radiology Clinician-Scientists
Supporting radiology clinician-scientists is essential for innovation — a strategic investment that can transform patient care and the future of academic medicine.
Read more2025 Intersociety Summer Conference Highlights
Read about recommendations made during the 2025 Intersociety Summer Conference to alleviate the degradation of the academic mission and its impact on radiology.
Read moreACR Provides Input to FDA on AI Measurement and Evaluation
ACR submitted comments to FDA on real-world AI device performance, stressing safety, governance, and continuous monitoring.
Read more